AlphaStocks
5.2
Consider Buy

INCYTE CORP (INCY)

Health Care / Biotechnology

S&P 500

$99.83

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#495out of 1126 in Health Care

Is INCYTE CORP a Good Investment in 2026?

INCYTE CORP (INCY) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates INCYTE CORP as Strong (7/9). The Graham model is the least favorable, rating it Neutral. INCYTE CORP ranks #495 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E15.6ROE26.0Market Cap21B

Valuation

Trades at 16x earnings — near sector median of 26x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

60% above fair value

Lynch

Strong

PEG 0.8 · Fast Grower

Greenblatt

Strong

Top half (rank 28%)

Frequently Asked Questions

Is INCYTE CORP (INCY) a good investment?
Based on AlphaStocks' composite analysis, INCYTE CORP (INCY) scores 5.2 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trades at 16x earnings — near sector median of 26x.
What is INCYTE CORP's Piotroski F-Score?
INCYTE CORP's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is INCY overvalued or undervalued?
A precise fair value estimate is not available for INCY. Trades at 16x earnings — near sector median of 26x.
How does INCY compare to other Health Care stocks?
INCYTE CORP ranks #495 out of 1126 stocks in the Health Care sector, placing it in the top 44% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about INCY?
AlphaStocks evaluates INCY using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.2/10.

Similar Stocks

Compare INCY with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer